MALAKOFF, France–(BUSINESS WIRE)–Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose vein treatment, publishes its 2025 financial results today and provides an update on its strategic progress and outlook for 2026. Martin Deterre, CEO, stated: “2025 was a decisive year for Theraclion. It confirmed that our technology is now a clinical and commercial rea